Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme
US7202065B2 · kind B2 · utility
6Cited by
7References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 3, 2002 |
| Grant date | Apr 10, 2007 |
| Priority date | — |
| Expiry date | Sep 2, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A stabilized liquid preparation of a protease which activates blood coagulation Factor VII or of its proenzyme is herein described. The preparation also contains one or more compounds selected from the group consisting of ornithine, diaminopimelic acid, agmatine, creatine, guanidinoacetic acid, acetylornithine, citrulline, arginoinosuccinic acid, tranexamic acid and epsilon-aminocaproic acid or their salts and has a pH of 2–8.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.